Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5013)
All Articles published online
|
Feb 7, 2012 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yusoff AR, Abdul Razak MM, Yoong BK, Vijeyasingam R, Siti ZM. Survival analysis of cholangiocarcinoma: A 10-year experience in Malaysia. World J Gastroenterol 2012; 18(5): 458-465 [PMID: 22346252 DOI: 10.3748/wjg.v18.i5.458] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i5/458.htm |
| Number | Citing Articles |
| 1 |
Surachate Siripongsakun, Withawat Sapthanakorn, Poemlarp Mekraksakit, Saruda Vichitpunt, Saowalak Chonyuen, Jitsupa Seetasarn, Siwat Bhumiwat, Thaniya Sricharunrat, Saowanee Srittanapong. Premalignant lesions of cholangiocarcinoma: characteristics on ultrasonography and MRI. Abdominal Radiology 2019; 44(6): 2133 doi: 10.1007/s00261-019-01951-2
|
| 2 |
Banchob Sripa, Wunchana Seubwai, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, Atit Silsirivanit, Worasak Kaewkong, Kanha Muisuk, Paweena Dana, Chatchai Phoomak, Worachart Lert-itthiporn, Vor Luvira, Chawalit Pairojkul, Bin T. Teh, Sopit Wongkham, Seiji Okada, Yaovalux Chamgramol. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. Human Cell 2020; 33(3): 695 doi: 10.1007/s13577-020-00334-w
|
| 3 |
Narong Khuntikeo, Nittaya Chamadol, Puangrat Yongvanit, Watcharin Loilome, Nisana Namwat, Paiboon Sithithaworn, Ross H. Andrews, Trevor N. Petney, Supannee Promthet, Kavin Thinkhamrop, Chaiwat Tawarungruang, Bandit Thinkhamrop. Cohort profile: cholangiocarcinoma screening and care program (CASCAP). BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1475-7
|
| 4 |
Denghua Yao, Vamsi Krishna Kunam, Xiao Li. A review of the clinical diagnosis and therapy of cholangiocarcinoma. Journal of International Medical Research 2014; 42(1): 3 doi: 10.1177/0300060513505488
|
| 5 |
Olaf Neumann, Timothy C. Burn, Michael Allgäuer, Markus Ball, Martina Kirchner, Thomas Albrecht, Anna-Lena Volckmar, Susanne Beck, Volker Endris, Hannah Goldschmid, Ulrich Lehmann, Huriye Seker-Cin, Sebastian Uhrig, Stephanie Roessler, Jan Budczies, Stefan Fröhling, Thomas Longerich, Alex H. Wagner, Arndt Vogel, Peter Schirmacher, Albrecht Stenzinger, Daniel Kazdal. Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing. British Journal of Cancer 2022; 127(8): 1540 doi: 10.1038/s41416-022-01908-1
|
| 6 |
Li-Hong Xing, Shu-Ping Wang, Li-Yong Zhuo, Yu Zhang, Jia-Ning Wang, Ze-Peng Ma, Ying-Jia Zhao, Shuang-Rui Yuan, Qian-He Zu, Xiao-Ping Yin. Comparison of Machine Learning Models Using Diffusion-Weighted Images for Pathological Grade of Intrahepatic Mass-Forming Cholangiocarcinoma. Journal of Imaging Informatics in Medicine 2024; 37(5): 2252 doi: 10.1007/s10278-024-01103-z
|
| 7 |
Elena V. Poddubskaya, Madina P. Baranova, Daria O. Allina, Philipp Y. Smirnov, Eugene A. Albert, Alexey P. Kirilchev, Alexey A. Aleshin, Marina I. Sekacheva, Maria V. Suntsova. Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma. Experimental Hematology & Oncology 2018; 7(1) doi: 10.1186/s40164-018-0113-x
|
| 8 |
Somkiattiyos Woradet, Supannee Promthet, Nopparat Songserm, Donald Maxwell Parkin. Factors Affecting Survival Time of Cholangiocarcinoma Patients: A Prospective Study in Northeast Thailand. Asian Pacific Journal of Cancer Prevention 2013; 14(3): 1623 doi: 10.7314/APJCP.2013.14.3.1623
|
| 9 |
Somkiattiyos Woradet, Nopparat Songserm, Supannee Promthet, Donald Maxwell Parkin, Helge Bruns. Health-Related Quality of Life and Survival of Cholangiocarcinoma Patients in Northeastern Region of Thailand. PLOS ONE 2016; 11(9): e0163448 doi: 10.1371/journal.pone.0163448
|
| 10 |
Li-Hong Xing, Li-Yong Zhuo, Jia-Ning Wang, Yan Zhang, Feng-Ying Zhu, Chu Wang, Xiao-Ping Yin, Bu-Lang Gao. Values of MRI Imaging Presentations in the Hepatobiliary Phase, DWI and T2WI Sequences in Predicting Pathological Grades of Intrahepatic Mass-Forming Cholangiocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.867702
|
| 11 |
Vor Luvira, Kasama Nilprapha, Vajarabhongsa Bhudhisawasdi, Ake Pugkhem, Nittaya Chamadol, Supot Kamsa-ard. Cholangiocarcinoma Patient Outcome in Northeastern Thailand: Single-Center Prospective Study. Asian Pacific Journal of Cancer Prevention 2016; 17(1): 401 doi: 10.7314/APJCP.2016.17.1.401
|
| 12 |
Dwaipayan Samaddar, Duraisamy Ravichandran Rajan, Jaya Bagchi Samaddar, Gautam Das. Spectrum of Cholangiocarcinoma with Special Emphasis on Treatment Modalities and Outcome at a Rural Tertiary Care Centre. Journal of Evolution of Medical and Dental Sciences 2020; 9(16): 1359 doi: 10.14260/jemds/2020/296
|
| 13 |
Pawalee Dowsiriroj, Permsak Paholpak, Winai Sirichativapee, Taweechok Wisanuyotin, Pat Laupattarakasem, Kamolsak Sukhonthamarn, Weerachai Kosuwon, Polasak Jeeravipoolvarn. Cholangiocarcinoma with spinal metastasis: Single center survival analysis. Journal of Clinical Neuroscience 2017; 38: 43 doi: 10.1016/j.jocn.2016.12.048
|
| 14 |
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park. Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study. Intestinal Research 2023; 21(2): 252 doi: 10.5217/ir.2022.00092
|
| 15 |
Inês Tavares, Ricardo Martins, Ilda Patrícia Ribeiro, Luísa Esteves, Francisco Caramelo, Ana Margarida Abrantes, Rita Neves, Rui Caetano-Oliveira, Maria Filomena Botelho, Joana Barbosa de Melo, Dulce Diogo, José Guilherme Tralhão, Isabel Marques Carreira. Development of a genomic predictive model for cholangiocarcinoma using copy number alteration data. Journal of Clinical Pathology 2022; 75(4): 274 doi: 10.1136/jclinpath-2020-207346
|
| 16 |
Prakongboon Sungkasubun, Surachate Siripongsakun, Kunlayanee Akkarachinorate, Sirachat Vidhyarkorn, Akeanong Worakitsitisatorn, Thaniya Sricharunrat, Sutida Singharuksa, Rawisak Chanwat, Chairat Bunchaliew, Sirima Charoenphattharaphesat, Ruechuta Molek, Maneenop Yimyaem, Gaidganok Sornsamdang, Kamonwan Soonklang, Kasiruck Wittayasak, Chirayu U. Auewarakul, Chulabhorn Mahidol. Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2390-2
|
| 17 |
Sakda Waraasawapati, Raksawan Deenonpoe, Prakasit Sa-ngiamwibool, Yaovalux Chamgramol, Chawalit Pairojkul. Diagnosis and Management of Cholangiocarcinoma. 2021; : 265 doi: 10.1007/978-3-030-70936-5_11
|
| 18 |
Shihong Li, Haizhen Qian, Yu Peng, Huihui Jia, Guangwu Lin. Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-08634-2
|
| 19 |
Yasmeena Hassan, Arif Akbar Bhat, Jahangir Mohi Uddin, Ishfaq Majeed, Mohd Younis Rather, Ajaz Ahmad Waza. Hepatic Cancer: Present Scenario, Treatment Options and Nursing Management. Biomedical and Pharmacology Journal 2023; 16(1): 419 doi: 10.13005/bpj/2623
|